Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2009
11/11/2009CN101574494A Drug for treating hepatitis B
11/11/2009CN101574476A Medicinal material composition used for lowering lipid and protecting liver auxiliarily
11/11/2009CN101574475A Polygonatum particle and preparation method thereof
11/11/2009CN101574473A Intestine and stomach resuscitation powder
11/11/2009CN101574460A Nourishing and health preserving liquid medicine
11/11/2009CN101574445A Traditional Chinese medicine composition with oral health efficacy
11/11/2009CN101574439A Method for controlling quality of Runzao Zhiyang tablet
11/11/2009CN101574429A Chinese medicinal herb for treating enteritis of beasts and fowls
11/11/2009CN101574426A Chinese patent medicament for treating liver diseases and method for preparing same
11/11/2009CN101574416A Heat-clearing Ganoderma lucidum polysaccharides health-care capsule
11/11/2009CN101574408A Traditional Chinese medicine composition and preparation thereof for health care and beautification
11/11/2009CN101574400A Chinese medicament containing gen-seng and cordyceps
11/11/2009CN101574397A WuRenChun self-emulsifying soft capsule preparation and preparation method
11/11/2009CN101574395A Method for producing schisandra extract by adopting high voltage pulse electric field technology
11/11/2009CN101574392A Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid
11/11/2009CN101574391A Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
11/11/2009CN101574388A Cordyceps oral solution and preparation method thereof
11/11/2009CN101574387A Quality control method for stringy stonecrop herb preparation
11/11/2009CN101574383A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginoside
11/11/2009CN101574382A Externally applied medicine for treating oral mucosa ulcer
11/11/2009CN101574375A Lactobacillus health-care capsule and preparation method thereof
11/11/2009CN101574352A Antitumor usage of 3-carbonyl-12-alkene-ursane compound
11/11/2009CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009CN101574320A Intestinal protection medicament and preparation method thereof
11/11/2009CN101574144A Application of 3'-deoxyadenosine in reducing weight, enhancing insulin sensitivity and improving lipid metabolism
11/11/2009CN100558883C New strains of bifidobacterium having the ability to produce glutamine
11/11/2009CN100558744C Use of a recombinant erythropoietin having high activity and reduced side effects
11/11/2009CN100558726C The enantiomer of tenatoprazole and the use thereof in therapy
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558717C Novel medicine
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/11/2009CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009CN100558407C Preparation of aqueous clear solution dosage forms with bile acids
11/11/2009CN100558380C Antidysenteric premixed agent for roaster
11/11/2009CN100558370C Adsorbent for oral administration
11/11/2009CN100558357C Medicine composition for treating mixed infectious disease
11/11/2009CN100558348C Sallowness preparation, its making method and quality control
11/11/2009CN100558347C Ginseng-astragalus dispersion tablet formulation, and its preparing process
11/11/2009CN100558255C Method for preparing ageratum and purple common perilla fish-jam
11/11/2009CN100558254C Method for preparing ageratum and elsholtzia type roasting jam
11/10/2009US7615576 Prevention of neutrophil recruitment
11/10/2009US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009US7615228 Chimeric protein containing specific polypeptide and a conserved fragment of hemagglutin antigen from influenza virus
11/10/2009US7615207 Methods for treating irritable bowel syndrome
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2421410C Iron compositions
11/10/2009CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009CA2411199C Recombinant bacterial phytases and uses thereof
11/10/2009CA2397614C Honey based wound dressing
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009132484A1 Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same
11/05/2009US20090275923 Electronic capsule for treating gastrointestinal disease
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275648 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
11/05/2009US20090275622 Nizatidine formulations
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009US20090275568 Fused quinoline derivative and use thereof
11/05/2009US20090275563 Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy
11/05/2009US20090275541 Method for treating neurocognitive dysfunction
11/05/2009US20090275537 Certain chemical entities, compositions, and methods
11/05/2009US20090275530 Gastric Raft Composition Comprising Preferably Processed Starches For Inducing Satiety
11/05/2009US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009US20090274784 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/05/2009US20090274766 Compositions and Methods For Inhibiting Gastric Acide Secretion Using Derivatives of Small Dicarboxylic Acids in Combination with PPI
11/05/2009US20090274756 Stabilized composition
11/05/2009US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009US20090274680 Human Phospholipases
11/05/2009US20090274662 Methods And Kits For The Treatment Of Inflammatory Bowel Disorder Conditions
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009US20090274636 Tooth enamel dissolution inhibitor
11/05/2009CA2722858A1 Substrate based pet imaging agents
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2112995A2 23-substituted bile acids as tgr5 modulators and methods of use thereof
11/04/2009EP2112920A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
11/04/2009EP1729823B1 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009EP1387620B1 Method for producing a nutrition additive, an additive and its use
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009CN101570528A Glycyrrhizin derivatives and preparation and use thereof
11/04/2009CN101569631A Anti tumor application of 3-carbonyl-20alpha-hydroxy-24-en-dammarane compound
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612083 Urea substituted imidazoquinoline ethers
11/03/2009US7612047 Degradation-resistant mononucleoside phosphate compounds
11/03/2009US7611730 Containing racemate of tramadol in slow-release form and (+)enantiomer of tramadol in immediate-release form; analgesic efficacy results from interplay of enantiomers by mechanism which includes non-opioid and opiod components
11/03/2009US7611729 Dosage forms having prolonged active ingredient release
11/03/2009US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009CA2514224C Liquid pharmaceutical formulations of palonosetron
11/03/2009CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 1258